Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danijel Kikelj

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
Peptidomimetic thrombin inhibitorsDanijel Kikelj
Chemmedchem|April 9, 2008
A successful joint effortDanijel Kikelj
Current Medicinal Chemistry|June 22, 2006
The application of Freidinger lactams and their analogs in the design of conformationally constrained peptidomimeticsAndrej Perdih, Danijel Kikelj
Acta Chimica Slovenica|September 25, 2013
Preparation and Reactivity of 5-benzylidenebarbituric and 5-benzylidene-2-thiobarbituric AcidsNace Zidar, Danijel Kikelj
Current Medicinal Chemistry|September 25, 2013
Isoform selective voltage-gated sodium channel modulators and the therapy of painMarko Jukič, Danijel Kikelj, Marko Anderluh
Mini Reviews in Medicinal Chemistry|September 28, 2013
2-Aminoimidazoles in medicinal chemistryAleš Žula, Danijel Kikelj, Janez Ilaš
Journal of Medicinal Chemistry|April 17, 2008
Novel potent and selective thrombin inhibitors based on a central 1,4-benzoxazin-3(4H)-one scaffoldJanez Ilas, Tihomir Tomasić, Danijel Kikelj
European Journal of Medicinal Chemistry|February 28, 2012
Fluorinated dual antithrombotic compounds based on 1,4-benzoxazine scaffoldMiloš Ilić, Danijel Kikelj, Janez Ilaš
European Journal of Medicinal Chemistry|May 7, 2013
Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb/IIIa with highly overlapped pharmacophoresUroš Trstenjak, Janez Ilaš, Danijel Kikelj
Future Medicinal Chemistry|May 23, 2018
Recent progress in the discovery and development of DNA gyrase B inhibitorsMichaela Barančoková, Danijel Kikelj, Janez Ilaš
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
Peptidomimetic thrombin inhibitorsDanijel Kikelj
Chemmedchem|April 9, 2008
A successful joint effortDanijel Kikelj
Current Medicinal Chemistry|June 22, 2006
The application of Freidinger lactams and their analogs in the design of conformationally constrained peptidomimeticsAndrej Perdih, Danijel Kikelj
Acta Chimica Slovenica|September 25, 2013
Preparation and Reactivity of 5-benzylidenebarbituric and 5-benzylidene-2-thiobarbituric AcidsNace Zidar, Danijel Kikelj
Current Medicinal Chemistry|September 25, 2013
Isoform selective voltage-gated sodium channel modulators and the therapy of painMarko Jukič, Danijel Kikelj, Marko Anderluh
Mini Reviews in Medicinal Chemistry|September 28, 2013
2-Aminoimidazoles in medicinal chemistryAleš Žula, Danijel Kikelj, Janez Ilaš
Journal of Medicinal Chemistry|April 17, 2008
Novel potent and selective thrombin inhibitors based on a central 1,4-benzoxazin-3(4H)-one scaffoldJanez Ilas, Tihomir Tomasić, Danijel Kikelj
European Journal of Medicinal Chemistry|February 28, 2012
Fluorinated dual antithrombotic compounds based on 1,4-benzoxazine scaffoldMiloš Ilić, Danijel Kikelj, Janez Ilaš
European Journal of Medicinal Chemistry|May 7, 2013
Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb/IIIa with highly overlapped pharmacophoresUroš Trstenjak, Janez Ilaš, Danijel Kikelj
Future Medicinal Chemistry|May 23, 2018
Recent progress in the discovery and development of DNA gyrase B inhibitorsMichaela Barančoková, Danijel Kikelj, Janez Ilaš
Pageof 11